The Globe and Mail reports in its Wednesday, April 20, edition that Raymond James analyst Steve Hansen, pointing to "better-than-expected" global methanol prices, increased his target for Methanex shares to $58 (U.S.) from $54 (U.S.). The Globe's David Leeder writes that Mr. Hansen continues to rate Methanex "market perform." Analysts on average target the shares at $56.17 (U.S.). Mr. Hansen says in a note: "We maintain our neutral view, drawing caution from: 1) methanol supply fundamentals that remain broadly unaffected by recent geopolitical events; 2) rising macroeconomic risks associated with the slowing global economy; 3) the more direct effect of China's extreme lock-down measures; and 4) the recent surge in domestic natural gas prices. We will continue to monitor accordingly." The Globe reported on Sept. 16, 2021, that Mr. Hansen kept Methanex at "outperform." Mr. Hansen said Methanex was "trading at a very deep discount." It was then worth $41 (Canadian). The Globe reported on Oct. 6 that Scotiabank rated Methanex "sector outperform" when it was worth $48.69 (Canadian). The Globe reported on Feb. 21, 2022, that Barclay's kept Methanex at "overweight" when it was worth $59.44 (Canadian).